FULGENT GENETICS INC (FLGT)
US3596641098 - Common Stock
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fulgent Genetics (NASDAQ:FLGT) just reported results for the first quarter of 2...
FLGT Stock Earnings: Fulgent Genetics Beats EPS, Misses Revenue for Q1 2024
FLGT stock results show that Fulgent Genetics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Fulgent Reports First Quarter 2024 Financial Results
Fulgent Genetics Enters Oversold Territory (FLGT)
Fulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
Fulgent Reports Fourth Quarter and Full Year 2023 Financial Results
Fulgent Genetics to Announce Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 28, 2024
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
/PRNewswire/ -- CooperSurgical®, a global leader in fertility and women's health, and Fulgent Genetics, Inc. (NASDAQ: FLGT), a technology-based company with a...
Noteworthy Wednesday Option Activity: AMRX, FLGT, DXCM
Commit To Purchase Fulgent Genetics At $25, Earn 15.5% Annualized Using Options
The 3 Best Digital Health Stocks for Personalized Medicine
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health.
Fulgent to Participate in the Piper Sandler 35th Annual Healthcare Conference
Fulgent Shares Data from Two Poster Presentations at SITC 2023 Annual Meeting
Fulgent Genetics Non-GAAP EPS of -$0.39 misses by $0.07, revenue of $84.69M beats by $20.27M (NASDAQ:FLGT)
Fulgent Genetics reports Q3 earnings: non-GAAP EPS misses by $0.07 and revenue beats expectations by $20.27M.
Fulgent Reports Third Quarter 2023 Financial Results
Notable Thursday Option Activity: FLGT, HELE, SIX
Fulgent Announces Two Poster Presentations at SITC 2023 Annual Meeting
Fulgent Genetics to Announce Third Quarter 2023 Financial Results on Friday November 3, 2023
Notable Wednesday Option Activity: LOW, FLGT, TPR
Notable Monday Option Activity: FLGT, CROX, IDT
Fulgent Reports Second Quarter 2023 Financial Results
Notable Thursday Option Activity: FLGT, CLW, SHAK
Commit To Purchase Fulgent Genetics At $35, Earn 90.4% Annualized Using Options
Exagen Inc. Appoints Paul Kim to Board of Directors
Fulgent Genetics to Announce Second Quarter 2023 Financial Results on Friday, August 4, 2023
Got $2,500? This Dirt Cheap Growth Stock Could Be Worth Buying Hand Over Fist
Fulgent is moving past its pandemic-era business, and that's a good thing.
Fulgent Data at ASCO 2023 Highlights Progress for Its Lead Therapeutic Oncology Candidate, FID-007, in Various Cancers
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics
Neither has a traditional business model, but that could be an asset for both.
2 Undervalued Stocks to Buy for Potentially Massive Gains in the Next 10 Years
Both are experiencing a bit of a hangover from declining COVID-19-related sales.
Bullish Two Hundred Day Moving Average Cross - FLGT
